Aveanna Healthcare Holdings Inc. AVAH
12.41
0.03
0.24%
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 9.5×
Follow AVAH
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.34 | 7.56 | 5.19 | 6.59 |
P/S ratio |
0.81 | 0.68 | 0.55 | 0.72 | |
P/FCF ratio |
22.46 | 14.04 | 10.70 | 11.79 | |
P/Operating CF |
55.82 | 33.44 | 317.77 | 23.06 | |
P/B ratio |
201.80 | 8.55 | 5.76 | 6.50 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.39 | 1.21 | 1.05 | 1.24 | |
EV/EBITDA |
11.94 | 10.10 | 8.62 | 10.50 | |
EV/Operating CF |
35.46 | 23.32 | 19.12 | 19.22 | |
EV/FCF |
38.48 | 24.78 | 20.55 | 20.41 | |
Quick Ratio |
1.13 | 1.20 | 1.34 | 1.07 | |
Current Ratio |
1.23 | 1.32 | 1.47 | 1.16 | |
Net Debt/EBITDA |
21.25 | 16.05 | 16.33 | 15.43 | |
Debt/Assets |
81.06% | 72.79% | 72.31% | 69.45% | |
Debt/Equity |
159.80 | 7.53 | 6.09 | 5.09 | |
Asset Turnover |
1.33 | 1.32 | 1.37 | 1.34 | |
Operating CF/Net income |
2.36 | 0.28 | 0.10 | 2.01 | |
Capex/Depreciation |
(0.23) | (0.24) | (0.53) | (0.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.34% | 14.74% | 14.78% | 14.48% | |
Intangible Assets out of Total Assets |
0.67 | 0.60 | 0.60 | 0.65 | |
Share Based Compensation of Revenue |
0.80% | 0.60% | 0.64% | 0.62% | |
Graham Net Nets |
(0.70) | (0.76) | (0.87) | (0.72) | |
Graham Number |
0.61 | 4.82 | 5.59 | 6.21 | |
Earnings Yield |
4.28% | 13.22% | 19.25% | 15.17% | |
Free Cash Flow Yield |
4.45% | 7.12% | 9.35% | 8.49% | |
Revenue per Share |
2.98 | 3.26 | 3.02 | 3.08 | |
Operating CF per Share |
0.16 | 0.24 | 0.02 | 0.37 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.15 | 0.23 | 0.00 | 0.37 | |
Cash per Share |
0.70 | 0.95 | 0.88 | 0.45 | |
Shareholders Equity per Share |
0.04 | 0.96 | 1.12 | 1.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.04 | 0.96 | 1.12 | 1.32 | |
Free Cash Flow |
31.18 | 47.77 | (0.21) | 79.64 | |
Working Capital |
92.91 | 135.78 | 184.87 | 66.77 | |
Capital Expenditures |
(2.02) | (1.95) | (4.56) | (1.29) | |
Net Current Asset Value |
(1,298.67) | (1,257.69) | (1,206.69) | (1,341.01) | |
EV/EBIT |
13.73 | 11.44 | 9.69 | 11.80 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | |
Net Profit Margin |
2.26% | 26.98% | 6.43% | 6.01% | |
Price to Operating Income |
8.02 | 6.48 | 5.04 | 6.81 | |
| Other line items | |||||
Average Receivables |
297.88 | 296.89 | 320.47 | 330.81 | |
Average Payables |
34.51 | 34.20 | 32.42 | 39.50 | |
Average Assets |
1,727.31 | 1,837.89 | 1,841.39 | 1,938.67 | |
Average Common Equity |
(73.63) | 35.46 | 69.96 | 137.64 |
Columns are period end dates